| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.26 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |